Preferred Label : pegvisomant;
MeSH note : is a genetically engineered analogue of human growth hormone that functions as a growth
hormone-receptor antagonist; used to treat Acromegaly;;
CISMeF synonym : Pharmacia brand of pegvisomant; B2036-PEG; pfizer brand of pegvisomant; somavert;
MeSH hyponym : B-2036 PEG;
Is substance : O;
UNII : N824AOU5XV;
Origin ID : C406545;
UMLS CUI : C0913469;
ATC code(s)
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Exact mapping(s) to DCI
MeSH indexing information
MeSH term(s) associated for indexing
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
http://www.has-sante.fr/portail/jcms/c_2572175/fr/somavert
2015
false
France
French
insurance, health, reimbursement
injections, subcutaneous
pegvisomant
treatment outcome
pegvisomant
pegvisomant
human growth hormone
acromegaly
orphan drug production
receptors, somatotropin
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1730032/fr/somavert-pegvisomant-antagoniste-du-recepteur-de-l-hormone-de-croissance
2014
false
false
false
France
French
pegvisomant
receptors, somatotropin
pegvisomant
pegvisomant
injections, subcutaneous
acromegaly
orphan drug production
insulin-like growth factor i
evaluation of the transparency committee
guidelines for drug use
human growth hormone
human growth hormone
human growth hormone
---
http://www.has-sante.fr/portail/display.jsp?id=c_399928
http://www.has-sante.fr/portail/jcms/c_1600988/fr/somavert
http://www.has-sante.fr/portail/jcms/c_1600987/fr/somavert-15052013-avis-ct12668
2013
France
French
insurance, health, reimbursement
injections, subcutaneous
pegvisomant
treatment outcome
pegvisomant
pegvisomant
human growth hormone
acromegaly
orphan drug production
receptors, somatotropin
evaluation of the transparency committee
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00138
2011
false
false
false
Canada
drug information
powders
pegvisomant
---
https://www.ema.europa.eu/medicines/human/EPAR/Somavert
2009
United Kingdom
French
English
syndication feed
human growth hormone
acromegaly
human growth hormone
human growth hormone
orphan drug production
pegvisomant
pegvisomant
drug evaluation
summary of product characteristics
package leaflet
---
http://www.meddispar.fr/medicaments/3622506
2008
France
French
injections
drug prescriptions
human growth hormone
legislation, drug
pegvisomant
pegvisomant
drug information
---
http://www.meddispar.fr/medicaments/3607837
2008
France
French
pegvisomant
human growth hormone
pharmaceutical solutions
injections
drug prescriptions
legislation, drug
pegvisomant
drug information
---
http://www.meddispar.fr/medicaments/3607843
2008
France
French
human growth hormone
pharmaceutical solutions
injections
drug prescriptions
legislation, drug
pegvisomant
pegvisomant
drug information
---
http://www.meddispar.fr/medicaments/3611810
2008
France
French
pegvisomant
human growth hormone
pharmaceutical solutions
injections
drug prescriptions
legislation, drug
pegvisomant
drug information
---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14035a-fra.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14518a-fra.php
2008
Canada
French
English
pegvisomant
canada
drug therapy, combination
human growth hormone
receptors, somatotropin
octreotide
acromegaly
transaminases
alanine transaminase
aspartate aminotransferases
liver
pharmacovigilance note
---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Somavert-Fr.pdf
2006
Canada
French
acromegaly
human growth hormone
human growth hormone
pegvisomant
pegvisomant
drug evaluation
---